I. Ferkolj, A. Ihan, S. Markovic, Z. Veceric, and M. Pohar, “Infliximab Reduces the Number of Activated Mucosal Lymphocytes in Patients with Crohn’s Disease”, JGLD, vol. 15, no. 3, pp. 231–235, Sep. 2006.